The pathogenic LRRK2 mutations (N1437H, R1441C/G/H, Y1699C, G2019S) associated with familial forms of PD increase phosphorylation of p62 and thereby enhance neurotoxicity [293] (Figure 2). This evidence concerns the gene LRRK2 and Parkinson disease.